Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Bullboard Posts
Comment by hiker1on Feb 11, 2012 11:35pm
177 Views
Post# 19521733

RE: Repost of dd page for newbies

RE: Repost of dd page for newbies

Thanks for posting that link,  MC;  I've passed it on to a few.

Nice board here,  everyone;  good mix of info and just having some fun.

Thinking of that one area in the release where it says that "Chemaphor has begun discussions with a number of multinationals companies and is examining a variety of strategic channels to market Oximunol(TM) Chewable in oversea markets.",    

This is an excellent business strategy to take,  in that,  working in foriegn countries, I would think, requires all sorts of legalites,  regulations,  approvals,  lawyers,  etc but by accessing large corporations already with a huge presence in those countries,  would elminate all that footwork, time and expense.    Kind of like working like Bill Gates;  you don't have to know it all;  you just have to surround yourself with folk that do.

 

Bullboard Posts